Article

Pharmacy Times Week in Review: April 1, 2016

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Featured article: Pharmacist Job Indicator Shows Improvement

Related Videos
Related Content
FDA website homepage -- Image credit: Postmodern Studio | stock.adobe.com
December 21st 2024

FDA Approves Alyftrek, Once-Daily CFTR Modulator for Cystic Fibrosis

Gillian McGovern, Assistant Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
Sleepless, man suffering from insomnia, sleep apnea or stress. Tired and exhausted guy. Headache or migraine. Awake in the night.
December 20th 2024

FDA Approves Tirzepatide as First Treatment for Moderate-to-Severe Obstructive Sleep Apnea in Adults With Obesity

Luke Halpern, Assistant Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Varicella zoster or chickenpox virus, ai illustration. A herpes virus which cause chickenpox and shingles - Image credit: Cristina | stock.adobe.com
December 20th 2024

Study: Fatal Disseminated Herpes Zoster in Immunocompetent Individuals

Kennedy Ferruggia, Assistant Editor
Close up image of skin texture suffering severe urticaria or hives or kaligata on back.
December 20th 2024

Patients With Chronic Idiopathic Urticaria at Higher Risk of Developing Food Allergies

Luke Halpern, Assistant Editor